Literature DB >> 9686694

Comparison of the current WHO and new ADA criteria for the diagnosis of diabetes mellitus in three ethnic groups in the UK. American Diabetes Association.

N Unwin1, K G Alberti, R Bhopal, J Harland, W Watson, M White.   

Abstract

The American Diabetes Association have recommended that the fasting plasma glucose level for the diagnosis of diabetes is lowered and that this becomes the main diagnostic test. We have used population-based data from three ethnic groups in Newcastle upon Tyne to examine the implications of this change. Data were available on 824 European (25-74 years), 375 Chinese (25-64 years), and 680 South Asian (25-74 years) subjects. All subjects apart from those reporting a prior diagnosis of diabetes underwent a standard 75 g oral glucose tolerance test (WHO criteria) which included the measurement of fasting glucose. The prevalence of diabetes was higher in all three ethnic groups using the new ADA criteria compared to the WHO criteria: 7.1% vs 4.8% in Europeans; 6.2% vs 4.7% in Chinese; and 21.4% vs 20.1% in South Asians. There was much variation in individuals categorized by the ADA and WHO criteria. Agreement between the two for the diagnosis of previously unknown diabetes was only moderate (kappa statistics 0.42 to 0.59). Thus in the populations studied the new criteria would increase the prevalence of diabetes in addition to classifying some individuals diabetic by current criteria as non-diabetic. It should be stressed however that diagnosis of the individual should not be based on a single test.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9686694     DOI: 10.1002/(SICI)1096-9136(199807)15:7<554::AID-DIA626>3.0.CO;2-E

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  13 in total

1.  New diagnostic criteria for diabetes mellitus. New criteria result in fewer cases in older adults.

Authors:  H E Resnick; T B Harris
Journal:  BMJ       Date:  1999-02-20

2.  Many South Asian people probably need pre-diabetes care.

Authors:  R Bhopal; C M Fischbacher
Journal:  BMJ       Date:  2002-10-26

Review 3.  What should we measure in the diabetic patient and how does this respond to therapy?

Authors:  Desmond G Johnston; Stephen Robinson; Shareen Forbes
Journal:  Br J Clin Pharmacol       Date:  2002-07       Impact factor: 4.335

4.  Undiagnosed diabetes: does it matter?

Authors:  T K Young; C A Mustard
Journal:  CMAJ       Date:  2001-01-09       Impact factor: 8.262

5.  Implementing intensive control of blood glucose concentration and blood pressure in type 2 diabetes in England: cost analysis (UKPDS 63).

Authors:  Alastair Gray; Philip Clarke; Andrew Farmer; Rury Holman
Journal:  BMJ       Date:  2002-10-19

6.  Lipid lowering in patients with diabetes mellitus: what coronary heart disease risk threshold should be used?

Authors:  K Rowland Yeo; W W Yeo
Journal:  Heart       Date:  2002-05       Impact factor: 5.994

7.  Screening for type 2 diabetes in a multiethnic setting using known risk factors to identify those at high risk: a cross-sectional study.

Authors:  Laura J Gray; Jennifer R Tringham; Melanie J Davies; David R Webb; Janet Jarvis; Timothy C Skinner; Azhar M Farooqi; Kamlesh Khunti
Journal:  Vasc Health Risk Manag       Date:  2010-10-05

8.  Prevalence and correlates of diabetes in South asian indians in the United States: findings from the metabolic syndrome and atherosclerosis in South asians living in america study and the multi-ethnic study of atherosclerosis.

Authors:  A M Kanaya; C L Wassel; D Mathur; A Stewart; D Herrington; M J Budoff; V Ranpura; K Liu
Journal:  Metab Syndr Relat Disord       Date:  2010-04       Impact factor: 1.894

9.  Hidden diabetes in the UK: use of capture-recapture methods to estimate total prevalence of diabetes mellitus in an urban population.

Authors:  Geoffrey V Gill; Aziz A Ismail; Nicholas J Beeching; Sarah B J Macfarlane; Mark A Bellis
Journal:  J R Soc Med       Date:  2003-07       Impact factor: 18.000

Review 10.  An overview of the eye in diabetes.

Authors:  Anil Negi; Stephen A Vernon
Journal:  J R Soc Med       Date:  2003-06       Impact factor: 18.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.